Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Baxter
Express Scripts
Dow
Mallinckrodt

Last Updated: August 15, 2022

Investigational Drug Information for Sulfatinib


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Sulfatinib?

Sulfatinib is an investigational drug.

There have been 17 clinical trials for Sulfatinib. The most recent clinical trial was a Phase 2 trial, which was initiated on December 7th 2015.

The most common disease conditions in clinical trials are Neuroendocrine Tumors, Neoplasms, and Carcinoid Tumor. The leading clinical trial sponsors are Hutchison Medipharma Limited, Peking University, and Fudan University.

There are four US patents protecting this investigational drug and forty-three international patents.

Recent Clinical Trials for Sulfatinib
TitleSponsorPhase
A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid TumorsHutchison Medipharma LimitedPhase 1/Phase 2
Open-label Study of Surufatinib in Japanese PatientsHutchison Medipharma LimitedPhase 1/Phase 2
Open-Label Surufatinib in European Patients With NETHutchison Medipharma LimitedPhase 2

See all Sulfatinib clinical trials

Clinical Trial Summary for Sulfatinib

Top disease conditions for Sulfatinib
Top clinical trial sponsors for Sulfatinib

See all Sulfatinib clinical trials

US Patents for Sulfatinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sulfatinib See Plans and Pricing Stable, concentrated radionuclide complex solutions ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L. (Pozzilli (Isernia), IT) See Plans and Pricing
Sulfatinib See Plans and Pricing Stable, concentrated radionuclide complex solutions ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L. (Pozzilli (Isernia), IT) See Plans and Pricing
Sulfatinib See Plans and Pricing Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use Hutchison MediPharma Limited (Shanghai, CN) See Plans and Pricing
Sulfatinib See Plans and Pricing Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use Hutchison Medipharma Limited (Shanghai, CN) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sulfatinib

Drugname Country Document Number Estimated Expiration Related US Patent
Sulfatinib Australia AU2018433575 2038-07-25 See Plans and Pricing
Sulfatinib Brazil BR112021001148 2038-07-25 See Plans and Pricing
Sulfatinib China CN112584875 2038-07-25 See Plans and Pricing
Sulfatinib China CN112867512 2038-07-25 See Plans and Pricing
Sulfatinib China CN112955188 2038-07-25 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Baxter
Express Scripts
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.